Creating a coordinated vaccine development capacity in Australia.
Addressing two of the greatest threats to global human health – pandemic virus emergence and antibiotic resistant superbugs.
Who is AVRA?
AVRA is a large team of lead scientists with vaccine expertise spanning investigative research, vaccine platforms, vaccine candidate generation, vaccine manufacturing and clinical trials.
A coordinated vaccine development pipeline will be the centrepiece of AVRA – structured to support nine key objectives to increase capability in vaccine development and delivery.
A team of professionals across a wide range of disciplines has been assembled to launch AVRA, across 3 of Australia’s leading research Universities.
A vaccine pipeline
AVRA is a new approach to addressing the barriers to vaccine production capability in Australia, leading to a vaccine pipeline that is industry-ready.